期刊文献+

急性心肌梗死患者优化介入再灌注治疗的临床研究进展 被引量:4

下载PDF
导出
摘要 急性心肌梗死(AMI)是指由于持久且严重的心肌缺血导致的部分心肌坏死。优化介入再灌注治疗是临床目前针对AMI患者的有效治疗方案,可帮助患者快速恢复冠状动脉循环,促进心肌血流良好灌注,降低病死率;但仍有少数患者由于心肌灌注不良而发生再梗死;造成心肌灌注不良的原因主要为微循环血管栓塞、微循环血管痉挛、微循环炎症水肿导致冠状动脉微循环发生障碍。抗血小板、血栓抽吸、抗炎等联合方式改善冠状动脉微循环功能的初步临床研究较理想,可降低无复流、慢血流发生率,有效改善心肌再灌注,现就冠状动脉内注射抗血栓药物、血栓抽吸等灌注方式进行综述。
作者 吕明月
出处 《医疗装备》 2020年第8期198-199,共2页 Medical Equipment
  • 相关文献

参考文献12

二级参考文献107

  • 1杨新春,张大鹏,王乐丰,徐立,葛永贵,王红石,李惟铭,倪祝华,夏昆,连勇,薛永利,马利祥.冠状动脉内应用国产替罗非班对急性ST段抬高心肌梗死急诊介入治疗后心肌灌注和临床预后的影响[J].中华心血管病杂志,2007,35(6):517-522. 被引量:73
  • 2Ito H, Okamura A, Iwakura K, et al.Myocardial perfusion patterns related to thrombolysis in myocardial infarction perfusion grades after coronary angioplasty in patients with acute anterior wall myocardial infarction[J].Circulation, 1996, 93: 1993-1999.
  • 3Tanaka A, Kawarabayashi T, Nishibori Y, et al.No-reflow phenomenon and lesion morphology in patients with acute myocardial infarction[J].Circulation, 2002, 105: 2148- 2152.
  • 4Yip HK, Chen MC, Chang HW, et al.Angiographic morphologic features of infarct-related arteries and timely reperfusion in acute myocardial infarction: predictors of slow-flow and no-reflow phenomenon[J].Chest, 2002, 122:1322-1332.
  • 5Hara M, Saikawa T, Tsunematsu Y, et al.Predicting no-reflow based on angiographic features of lesions in patients with acute myocardial infarction[J].J Atheroscler Thromb, 2005, 12:315-321.
  • 6Chesebro JH, Knatterud G, Roberts R, et al.Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase.Clinical findings through hospital discharge[J].Circulation, 1987, 76:142-154.
  • 7Gibson CM, Cannon CP, Murphy SA, et al.Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs[J].Circulation, 2000, 101:125-130.
  • 8O′Gara PT, Kushner FG, Ascheim DD,et al.2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction:a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines[J].J Am Coll Cardiol, 2013,61:e78-e140.
  • 9Hillegass WB, Dean NA, Liao L, et al.Treatment of no-reflow and impaired flow with the nitric oxide donor nitroprusside following percutaneous coronary interventions: initial human clinical experience[J].J Am Coll Cardiol, 2001, 37: 1335-1343.
  • 10Niccoli G, D′amario D, Spaziani C, et al.Randomized evaluation of intracoronary nitroprusside vs.adenosine after thrombus aspiration during primary percutaneous coronary intervention for the prevention of no-reflow in acute myocardial infarction: the REOPEN-AMI study protocol[J].J Cardiovasc Med (Hagerstown), 2009,10:585-592.

共引文献205

同被引文献76

引证文献4

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部